Evidence map›Paper›PMID 34069203›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Prognostic Impact of Pretreatment 2-[

Domenico Albano, Francesco Dondi, Angelica Mazzoletti, Pietro Bellini, Raffaele Giubbini, Francesco Bertagna

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Journal of cancer research and clinical oncology · 2025
    Article
  4. Baseline and interimFrontiers in oncology · 2024
    Article
  5. Metabolic tumour volume onScientific reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Domenico AlbanoNuclear Medicine Department, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.ORCID 0000-0003-0810-6494
Francesco DondiNuclear Medicine Department, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
Angelica MazzolettiNuclear Medicine Department, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
Pietro BelliniNuclear Medicine Department, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
Raffaele GiubbiniNuclear Medicine Department, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
Francesco BertagnaNuclear Medicine Department, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
University of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyHumansPositron-Emission TomographyPrognosisRetrospective StudiesFluorodeoxyglucose F182-[18F]-FDG PET/CTdiffuse large B cell lymphomaMTVprimary gastric DLBCLprognosisTLG

Identifiers

PMID34069203
PMCPMC8156603
OpenAlexW3161244643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.